|
|
||||||||
Gastrointestinal Imaging |
1 From the Department of Radiology, Charité Medical University Center, Campus Virchow Clinic, Humboldt University, D-13344 Berlin, Germany (E.L.H., T.J.V., W.P., J.B., R. Felix); the Department of Radiology, St.-Hedwig-Hospitals of Berlin, Germany (R. Felfe); and Schering, Berlin, Germany (W.C.). Received August 4; revision requested September 24; revision received November 24; accepted December 7. Address correspondence to E.L.H. (e-mail: elh@charite.de).
PURPOSE: To evaluate the effect of iodine concentration on the detection of focal liver lesions at biphasic spiral computed tomography (CT).
MATERIALS AND METHODS: One hundred two patients (64 men, 38 women) with neoplastic (n = 85) and nonneoplastic focal lesions (n = 17) were prospectively assigned to biphasic injection group A or B and received 180 mL of iopromide containing 370 or 300 mg of iodine per milliliter, respectively, during spiral CT. Comparison included assessment of quantitative and qualitative parameters.
RESULTS: Hepatic time-attenuation curves and mean hepatic enhancement in the portal venous phase and aortic time-attenuation curves in both arterial and portal venous phases were statistically superior in group A compared with group B. There was no significant difference in the mean enhancement in all lesions in either group. In contrast, among patients with hepatocellular carcinoma, mean contrast enhancement in lesions in the arterial phase was significantly superior in group A compared with group B. Blinded readers classified hepatic attenuation and lesion visibility as very good and as improved significantly more often in group A than in group B.
CONCLUSION: A decrease in iodine concentration significantly affects aortic and hepatic contrast enhancement and may impair the detectability of focal liver lesions during biphasic spiral CT.
Index terms: Aorta, CT, 981.12911, 981.12912, 981.12914, 981.12915 Computed tomography (CT), contrast media, 761.12112, 761.12114 Computed tomography (CT), helical, 761.12115 Contrast media, comparative studies Iodine and iodine compounds Liver, CT, 761.12111, 761.12112, 761.12114, 761.12115 Liver neoplasms, 761.312, 761.319, 761.321, 761.323 Liver neoplasms, secondary, 761.332
This article has been cited by other articles:
![]() |
X. Ma, A. E. Samir, N.-S. Holalkere, and D. V. Sahani Optimal Arterial Phase Imaging for Detection of Hypervascular Hepatocellular Carcinoma Determined by Continuous Image Capture on 16-MDCT Am. J. Roentgenol., September 1, 2008; 191(3): 772 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Ho, R. C. Nelson, and D. M. DeLong Determining Contrast Medium Dose and Rate on Basis of Lean Body Weight: Does This Strategy Improve Patient-to-Patient Uniformity of Hepatic Enhancement during Multi-Detector Row CT? Radiology, May 1, 2007; 243(2): 431 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Schima, R. Hammerstingl, C. Catalano, L. Marti-Bonmati, E. J. Rummeny, F. T. Montero, A. Dirisamer, B. Westermayer, M. Bellomi, D. Brisbois, et al. Quadruple-phase MDCT of the liver in patients with suspected hepatocellular carcinoma: effect of contrast material flow rate. Am. J. Roentgenol., June 1, 2006; 186(6): 1571 - 1579. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yagyu, K. Awai, M. Inoue, R. Watai, T. Sano, H. Hasegawa, and Y. Nishimura MDCT of Hypervascular Hepatocellular Carcinomas: A Prospective Study Using Contrast Materials with Different Iodine Concentrations Am. J. Roentgenol., May 1, 2005; 184(5): 1535 - 1540. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Awai, M. Inoue, Y. Yagyu, M. Watanabe, T. Sano, S. Nin, R. Koike, Y. Nishimura, and Y. Yamashita Moderate versus High Concentration of Contrast Material for Aortic and Hepatic Enhancement and Tumor-to-Liver Contrast at Multi-Detector Row CT Radiology, December 1, 2004; 233(3): 682 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Furuta, K. Ito, T. Fujita, S. Koike, A. Shimizu, and N. Matsunaga Hepatic Enhancement in Multiphasic Contrast-Enhanced MDCT: Comparison of High- and Low-Iodine-Concentration Contrast Medium in Same Patients with Chronic Liver Disease Am. J. Roentgenol., July 1, 2004; 183(1): 157 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Dorio, F. T. Lee Jr., K. P. Henseler, M. Pilot, M. A. Pozniak, T. C. Winter III, and S. A. Shock Using a Saline Chaser to Decrease Contrast Media in Abdominal CT Am. J. Roentgenol., April 1, 2003; 180(4): 929 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Awai, K. Takada, H. Onishi, and S. Hori Aortic and Hepatic Enhancement and Tumor-to-Liver Contrast: Analysis of the Effect of Different Concentrations of Contrast Material at Multi-Detector Row Helical CT Radiology, September 1, 2002; 224(3): 757 - 763. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |